Lei Shi

Lei Shi currently serves as the Senior Vice President at Biointron Biological Inc., overseeing research operations that provide antibody discovery services to a vast client base globally. Previous roles include Vice President and General Manager at Virtuoso Therapeutics, Executive Director of Antibody Discovery at Zai Lab, and Senior Director of Antibody Discovery at RuiYi, Inc. (now BirdRockBio), focusing on the discovery of functional antibodies. Early career milestones include positions as Senior Research Scientist at Centyrex (Johnson & Johnson) and Centocor (Johnson & Johnson), where Lei Shi led research teams and developed innovative protein display technologies. Academic contributions include an Instructor position at Harvard Medical School-MGH, with significant research in immunology and animal modeling. Educational qualifications encompass a Master of Science in Business Administration and Management from the University of Pennsylvania and a PhD in Molecular Biology from the University of Illinois Chicago.